Product & Service Providers in: ADMIXTURE COMPOUNDING SERVICES (503B OUTSOURCING FACILITIES) 340B IV/INFUSION ADHERENCE As Seen In: View Fagron Sterile Services’ Profile:
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 5 July 2022 – 7AM CET Fagron expands its US sterile compounding footprint with East coast acquisition Fagron, the
Advance your practice through powerful education and networking opportunities at the ASHP 2022 Summer Meetings in Phoenix, AZ. View Fagron Sterile Services’ Booth:
In an industry dealing with supply issues, health systems and labs need a reliable sterile services and raw ingredients supplier. Fagron Sterile Services (FSS) meets
503B Outsourcing Facility FDA registered 503B compounding facility with over 14,000 ft² of dedicated cGMP clean room suites FDA-inspected, in-house quality assurance testing Your patient’s
Fagron Sterile Services US (FSS) offers exceptional service to health systems, hospitals, ambulatory surgery centers and physician offices in need of reliable 503B Outsourcing to
Wichita, Kansas, March 15, 2022 – Fagron, a leading FDA Registered 503B Outsourcing Facility and a national supplier of compound sterile preparations, is expanding their
Fagron is excited to share our continued partnership with Premier and the renewal of our GPO contract. This agreement covers Fagron’s entire high-quality portfolio, ready
Product & Service Providers in: ADMIXTURE COMPOUNDING SERVICES (503B OUTSOURCING FACILITIES) 340B IV/INFUSION ADHERENCE As Seen In: View Fagron Sterile Services’ Ad:
MasterControl at Fagron: Rapid Production of High-Quality Drug Products Fagron Sterile Services US (FSS) is a 503B Outsourcing Provider vertically integrated with Fagron, a leader